Epitomvest

Epitomvest is a financial services entity registered in the Netherlands, with a recorded address at Oude Delft 111B, Delft, South Holland. The company was founded on 27 June 2023, making it a relatively new participant in the financial markets.

As of the time of this review, Epitomvest does not hold any regulatory licence from a recognised financial authority. This absence of regulation is a significant factor for any trader considering engaging with the broker, as it means there is no independent oversight of its operations.

Our records show that Epitomvest has no registered regulators on file. This was verified against public registers and industry databases. In the Netherlands, financial service providers are typically overseen by the Dutch Authority for the Financial Markets (AFM) or De Nederlandsche Bank (DNB), but Epitomvest does not appear on either register as a licenced entity.

Without a regulatory licence, client funds are not protected by investor compensation schemes or dispute resolution mechanisms that are standard for regulated brokers. Traders should be aware that operating with an unregulated broker carries heightened counterparty risk.

Epitomvest is registered at a physical address in the historic city of Delft, Netherlands. The address—Oude Delft 111B—is a verified commercial location. The company's incorporation date of June 2023 is recent, and there is limited publicly available information about its operational history or business activities.

The Netherlands is generally a respected jurisdiction for financial services, but registration as a commercial entity does not equate to regulatory authorisation. The company's legal registration alone does not guarantee adherence to financial conduct standards.

At present, there is no official website or verified online presence for Epitomvest that we could locate through independent web searches. The lack of a website is a major transparency concern, as legitimate brokers typically maintain a professional online presence to provide information about their services, terms, and contact details.

In the absence of an official site, it is not possible to verify the broker's claimed products, trading platforms, account types, or fee structures. This lack of verifiable public information makes it difficult for prospective clients to conduct proper due diligence.

FXCanary has assigned Epitomvest a Scam Risk Score of 49 out of 100, which falls into the 'Guarded' category. This score reflects the combination of the broker's unregulated status, recent incorporation, and lack of public information. The score is not a definitive label of fraud, but it signals a need for extreme caution.

Without regulatory oversight, clients have no recourse if the broker fails to honour withdrawals or engages in problematic practices. The absence of transparency further compounds the risk. Traders are advised to thoroughly verify any broker before committing funds, and to consider only regulated entities for their trading activities.

Given the limited information and unregulated status, Epitomvest is not suitable for most retail traders. Experienced traders who fully understand the risks of dealing with an unregulated entity might consider it, but only after exhaustive due diligence—which is currently hindered by the lack of a website.

At this stage, Epitomvest appears to be a high-risk proposition. Traders requiring regulatory protection, transparency, or a well-established track record should look elsewhere. The broker may appeal to those seeking very high-risk speculative engagements, but that is not a recommendation.

The known facts about Epitomvest paint a picture of a recently registered Dutch company with no regulatory licences and no online footprint. This combination of factors is unusual for a legitimate financial broker and should serve as a red flag for potential clients.

We will update this profile as more information becomes available. In the meantime, traders are strongly advised to exercise extreme caution and to prioritise regulated alternatives when choosing a broker for forex or CFD trading.